FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912305414> ?p ?o ?g. }

• W2912305414 abstract "Immunochemotherapy, the combined use of immunotherapy and chemotherapy, has demonstrated great promise in several cancers. LTX-315 is an oncolytic peptide with potent immunomodulatory properties designed for the local treatment of solid tumors. By inducing rapid immunogenic cell death through the release of danger-associated molecular pattern molecules (DAMPs), LTX-315 is capable of reshaping the tumor microenvironment, turning cold tumors hot through a significant increase in tumor-infiltrating lymphocytes.We investigated the potential of LTX-315 to be used in combination with standard-of-care chemotherapy (doxorubicin, brand name CAELYX®) against triple-negative breast cancer in an orthotopic 4 T1 mammary fat pad model. Tumor growth curves were compared using one-way ANOVA analysis of variance and Tukey's multiple comparisons test, and animal survival curves were compared using the log-rank (Mantel-Cox) test. We considered p values ≤0.05 to indicate statistical significance.We found that LTX-315 displayed a strong additive antitumoral effect when used in combination with CAELYX®, and induced immune-mediated changes in the tumor microenvironment, followed by complete regression in the majority of animals treated. Furthermore, imaging techniques and histological examination showed that the combination induced strong local necrosis, followed by an increase in the infiltration of CD4+ and CD8+ immune cells into the tumor parenchymal tissue.Our data demonstrate that LTX-315 is a promising combination partner with CAELYX® for the treatment of triple-negative breast cancer." @default.
• W2912305414 created "2019-02-21" @default.
• W2912305414 creator A5002401677 @default.
• W2912305414 creator A5016092761 @default.
• W2912305414 creator A5019460893 @default.
• W2912305414 creator A5053950619 @default.
• W2912305414 creator A5067305238 @default.
• W2912305414 creator A5068603373 @default.
• W2912305414 creator A5079694124 @default.
• W2912305414 creator A5091164296 @default.
• W2912305414 date "2019-01-22" @default.
• W2912305414 modified "2023-10-18" @default.
• W2912305414 title "Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model" @default.
• W2912305414 cites W1551811315 @default.
• W2912305414 cites W1834989319 @default.
• W2912305414 cites W1858187709 @default.
• W2912305414 cites W2001603742 @default.
• W2912305414 cites W2011714769 @default.
• W2912305414 cites W2012522456 @default.
• W2912305414 cites W2023485889 @default.
• W2912305414 cites W2040168715 @default.
• W2912305414 cites W2042198735 @default.
• W2912305414 cites W2054602599 @default.
• W2912305414 cites W2059409197 @default.
• W2912305414 cites W2079315541 @default.
• W2912305414 cites W2106694587 @default.
• W2912305414 cites W2120338564 @default.
• W2912305414 cites W2120426523 @default.
• W2912305414 cites W2125954922 @default.
• W2912305414 cites W2134878729 @default.
• W2912305414 cites W2136007332 @default.
• W2912305414 cites W2137520143 @default.
• W2912305414 cites W2140996651 @default.
• W2912305414 cites W2143145234 @default.
• W2912305414 cites W2153099927 @default.
• W2912305414 cites W2156491299 @default.
• W2912305414 cites W2157058802 @default.
• W2912305414 cites W2158482458 @default.
• W2912305414 cites W2179072674 @default.
• W2912305414 cites W2284926981 @default.
• W2912305414 cites W2293998220 @default.
• W2912305414 cites W2301251359 @default.
• W2912305414 cites W2337521097 @default.
• W2912305414 cites W2344131021 @default.
• W2912305414 cites W2345480690 @default.
• W2912305414 cites W2493491500 @default.
• W2912305414 cites W2521963431 @default.
• W2912305414 cites W2551893887 @default.
• W2912305414 cites W2560367415 @default.
• W2912305414 cites W2560836545 @default.
• W2912305414 cites W2570618306 @default.
• W2912305414 cites W2591017015 @default.
• W2912305414 cites W2612261621 @default.
• W2912305414 cites W2613910130 @default.
• W2912305414 cites W2626206073 @default.
• W2912305414 cites W2744067212 @default.
• W2912305414 cites W2761810380 @default.
• W2912305414 cites W2790541566 @default.
• W2912305414 cites W2799415594 @default.
• W2912305414 doi "https://doi.org/10.1186/s13058-018-1092-x" @default.
• W2912305414 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6343247" @default.
• W2912305414 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30670061" @default.
• W2912305414 hasPublicationYear "2019" @default.
• W2912305414 type Work @default.
• W2912305414 sameAs 2912305414 @default.
• W2912305414 citedByCount "40" @default.
• W2912305414 countsByYear W29123054142019 @default.
• W2912305414 countsByYear W29123054142020 @default.
• W2912305414 countsByYear W29123054142021 @default.
• W2912305414 countsByYear W29123054142022 @default.
• W2912305414 countsByYear W29123054142023 @default.
• W2912305414 crossrefType "journal-article" @default.
• W2912305414 hasAuthorship W2912305414A5002401677 @default.
• W2912305414 hasAuthorship W2912305414A5016092761 @default.
• W2912305414 hasAuthorship W2912305414A5019460893 @default.
• W2912305414 hasAuthorship W2912305414A5053950619 @default.
• W2912305414 hasAuthorship W2912305414A5067305238 @default.
• W2912305414 hasAuthorship W2912305414A5068603373 @default.
• W2912305414 hasAuthorship W2912305414A5079694124 @default.
• W2912305414 hasAuthorship W2912305414A5091164296 @default.
• W2912305414 hasBestOaLocation W29123054141 @default.
• W2912305414 hasConcept C121608353 @default.
• W2912305414 hasConcept C126322002 @default.
• W2912305414 hasConcept C142724271 @default.
• W2912305414 hasConcept C143998085 @default.
• W2912305414 hasConcept C167672396 @default.
• W2912305414 hasConcept C203014093 @default.
• W2912305414 hasConcept C2776107976 @default.
• W2912305414 hasConcept C2776694085 @default.
• W2912305414 hasConcept C2777701055 @default.
• W2912305414 hasConcept C2777877232 @default.
• W2912305414 hasConcept C2780110267 @default.
• W2912305414 hasConcept C2780140570 @default.
• W2912305414 hasConcept C2781303535 @default.
• W2912305414 hasConcept C502942594 @default.
• W2912305414 hasConcept C530470458 @default.
• W2912305414 hasConcept C71924100 @default.
• W2912305414 hasConcept C82210918 @default.
• W2912305414 hasConcept C8891405 @default.
• W2912305414 hasConceptScore W2912305414C121608353 @default.

• next